ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $92,345,000 | +7481.7% | 1,993,194 | +3888.3% | 0.04% | +414.3% |
| Q1 2019 | $1,218,000 | +1223.9% | 49,976 | +377.3% | 0.01% | – |
| Q4 2016 | $92,000 | +119.0% | 10,471 | +4.4% | 0.00% | – |
| Q4 2015 | $42,000 | -12.5% | 10,029 | -3.9% | 0.00% | – |
| Q3 2015 | $48,000 | -36.0% | 10,434 | 0.0% | 0.00% | – |
| Q2 2015 | $75,000 | -6.2% | 10,434 | -3.4% | 0.00% | – |
| Q1 2015 | $80,000 | +116.2% | 10,802 | +5.0% | 0.00% | – |
| Q3 2014 | $37,000 | -21.3% | 10,287 | 0.0% | 0.00% | – |
| Q2 2014 | $47,000 | -2.1% | 10,287 | 0.0% | 0.00% | – |
| Q1 2014 | $48,000 | -7.7% | 10,287 | 0.0% | 0.00% | – |
| Q4 2013 | $52,000 | – | 10,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
| KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
| Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
| QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
| APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
| FBR & Co. | 113,500 | $706,000 | 1.07% |
| Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
| Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
| Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |